Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Cephalon/Leo neurological disease collaboration

Nov. 20, 1996

Antimigraine drug from Vanguard to enter pivotal trials

Nov. 20, 1996

Peripheral opiate antihyperalgesic from Adolor in clinical trials

Nov. 20, 1996

SKB reports D3-selective antipsychotic agents

Nov. 20, 1996

Analgesic kappa-opioid agonists reported by Pfizer

Nov. 20, 1996

Daiichi discloses cerebroprotective agents

Nov. 15, 1996

IL-6 as a target for Alzheimer's disease drug design

Nov. 15, 1996

New MS treatment approved in Israel

Nov. 15, 1996

AutoImmune's MS therapeutic in final stages of development

Nov. 15, 1996

Rx for Parkinson's disease from NeuroSearch/BMS enters phase II

Nov. 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...